药品信息:
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(202122200334618.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- 部分中文左旋沙丁胺醇溶液处方资料(仅供参考)
【英文名称】Xopenex
【适用证】
治疗或预防成人,青少年和6岁及以上可逆性阻塞性气道疾病患儿的支气管痉挛。
【用法用量】
•仅限口服吸入
•6-11岁儿童:通过雾化每天三次,每次0.31毫克。 常规剂量不应超过每天三次0.63毫克。
•≥12岁的成人和青少年:通过雾化每天三次,每次6至8小时给予0.63mg。 最大推荐剂量为每天三次1.25毫克。
用于与空气压缩机连接的标准喷射雾化器(带面罩或接口管)。
【剂量形式和强度】
吸入溶液(用于雾化的单位剂量小瓶):0.31mg / 3mL,0.63mg / 3mL和1.25mg / 3mL。
【警告和注意事项】
•可能发生危及生命的反常支气管痉挛。 立即停用XOPENEX吸入溶液并用替代疗法治疗。
•需要更多剂量的XOPENEX吸入溶液可能是哮喘恶化的标志,需要重新评估治疗。
•XOPENEX吸入溶液不能替代皮质类固醇。
•可能会发生心血管效应。 如果发生这些影响,请考虑停用XOPENEX吸入溶液。 对患有潜在心血管疾病的患者慎用。
•过度使用可能是致命的。 不要超过推荐剂量。
•可能会发生即时超敏反应。 立即停用XOPENEX吸入溶液。
•可能发生低钾血症和血糖变化。
【不良反应】
最常见的不良反应是:心悸,胸痛,心动过速,头痛,头晕,震颤和紧张。
【INDICATIONS AND USAGE】
XOPENEX (levalbuterol hydrochloride) Inhalation Solution is a beta2-adrenergic agonist indicated for:
• Treatment or prevention of bronchospasm in adults, adolescents, and children 6 years of age and older with reversible obstructive airway disease.
【DOSAGE AND ADMINISTRATION】
• FOR ORAL INHALATION ONLY
• Children 6-11 years old: 0.31 mg administered three times a day, by nebulization. Routine dosing should not exceed 0.63 mg three times a day.
• Adults and Adolescents ≥12 years old: 0.63 mg administered three times a day, every 6 to 8 hours, by nebulization. The maximum recommended dose is 1.25 mg three times a day.
For use with a standard jet nebulizer (with a face mask or mouthpiece) connected to an air compressor.
【DOSAGE FORMS AND STRENGTHS 】
Inhalation Solution (unit-dose vial for nebulization): 0.31 mg/3 mL, 0.63 mg/3 mL and 1.25 mg/3 mL.
【WARNINGS AND PRECAUTIONS】
• Life-threatening paradoxical bronchospasm may occur. Discontinue XOPENEX Inhalation Solution immediately and treat with alternative therapy.
• Need for more doses of XOPENEX Inhalation Solution than usual may be a sign of deterioration of asthma and requires reevaluation of treatment.
• XOPENEX Inhalation Solution is not a substitute for corticosteroids.
• Cardiovascular effects may occur. Consider discontinuation of XOPENEX Inhalation Solution if these effects occur. Use with caution in patients with underlying cardiovascular disorders.
• Excessive use may be fatal. Do not exceed recommended dose.
• Immediate hypersensitivity reactions may occur. Discontinue XOPENEX Inhalation Solution immediately.
• Hypokalemia and changes in blood glucose may occur.
--------------------------------------------------------------- 详细处方信息以本药内容附件PDF文件(202122200334618.pdf)的“原文Priscribing Information”为准 --------------------------------------------------------------- |